Renal infarction in a patient with thyrotoxicosis‐induced atrial fibrillation treated successfully with dabigatran, a case report and literature review
<p dir="ltr">Renal infarction is an underdiagnosed condition with multiple possible causes, including atrial fibrillation. The treatment approach includes percutaneous endovascular therapy (PET) to restore blood flow, antiplatelet therapy, anticoagulation, or combination therapy, dep...
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | , , , , |
| Published: |
2022
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1864513546439622656 |
|---|---|
| author | Anas Al‐sadi (17746794) |
| author2 | Mohammed Abdulgayoom (14777791) Mohammed Alamin (20375244) Jouhar Kolleri (21397856) Israa Jawarneh (17746803) Qusai Almaharmeh (21606182) |
| author2_role | author author author author author |
| author_facet | Anas Al‐sadi (17746794) Mohammed Abdulgayoom (14777791) Mohammed Alamin (20375244) Jouhar Kolleri (21397856) Israa Jawarneh (17746803) Qusai Almaharmeh (21606182) |
| author_role | author |
| dc.creator.none.fl_str_mv | Anas Al‐sadi (17746794) Mohammed Abdulgayoom (14777791) Mohammed Alamin (20375244) Jouhar Kolleri (21397856) Israa Jawarneh (17746803) Qusai Almaharmeh (21606182) |
| dc.date.none.fl_str_mv | 2022-12-05T03:00:00Z |
| dc.identifier.none.fl_str_mv | 10.1002/ccr3.6693 |
| dc.relation.none.fl_str_mv | https://figshare.com/articles/journal_contribution/Renal_infarction_in_a_patient_with_thyrotoxicosis_induced_atrial_fibrillation_treated_successfully_with_dabigatran_a_case_report_and_literature_review/29413310 |
| dc.rights.none.fl_str_mv | CC BY 4.0 info:eu-repo/semantics/openAccess |
| dc.subject.none.fl_str_mv | Biomedical and clinical sciences Cardiovascular medicine and haematology Clinical sciences Pharmacology and pharmaceutical sciences Renal infarction Acute kidney ischemia Atrial fibrillation Hyperthyroidism complications Anticoagulation therapy |
| dc.title.none.fl_str_mv | Renal infarction in a patient with thyrotoxicosis‐induced atrial fibrillation treated successfully with dabigatran, a case report and literature review |
| dc.type.none.fl_str_mv | Text Journal contribution info:eu-repo/semantics/publishedVersion text contribution to journal |
| description | <p dir="ltr">Renal infarction is an underdiagnosed condition with multiple possible causes, including atrial fibrillation. The treatment approach includes percutaneous endovascular therapy (PET) to restore blood flow, antiplatelet therapy, anticoagulation, or combination therapy, depending on the patient's status and available modalities. Warfarin is the standard anticoagulation therapy, although direct oral anticoagulation (DOAC) therapy is getting more popular. Here, we present a 60‐year‐old male patient with hyperthyroidism complicated by acute renal infarction, which was successfully treated with dabigatran, evident by non‐recurrence and restoration of blood flow in a follow‐up CT angiogram. This case report may open the door for the use of DOAC in acute renal infarction though more studies are needed to prove the efficacy.</p><h2>Other Information</h2><p dir="ltr">Published in: Clinical Case Reports<br>License: <a href="http://creativecommons.org/licenses/by/4.0/" target="_blank">http://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.1002/ccr3.6693" target="_blank">https://dx.doi.org/10.1002/ccr3.6693</a></p> |
| eu_rights_str_mv | openAccess |
| id | Manara2_2ebce493cbfb5fe659ae20ffe5157827 |
| identifier_str_mv | 10.1002/ccr3.6693 |
| network_acronym_str | Manara2 |
| network_name_str | Manara2 |
| oai_identifier_str | oai:figshare.com:article/29413310 |
| publishDate | 2022 |
| repository.mail.fl_str_mv | |
| repository.name.fl_str_mv | |
| repository_id_str | |
| rights_invalid_str_mv | CC BY 4.0 |
| spelling | Renal infarction in a patient with thyrotoxicosis‐induced atrial fibrillation treated successfully with dabigatran, a case report and literature reviewAnas Al‐sadi (17746794)Mohammed Abdulgayoom (14777791)Mohammed Alamin (20375244)Jouhar Kolleri (21397856)Israa Jawarneh (17746803)Qusai Almaharmeh (21606182)Biomedical and clinical sciencesCardiovascular medicine and haematologyClinical sciencesPharmacology and pharmaceutical sciencesRenal infarctionAcute kidney ischemiaAtrial fibrillationHyperthyroidism complicationsAnticoagulation therapy<p dir="ltr">Renal infarction is an underdiagnosed condition with multiple possible causes, including atrial fibrillation. The treatment approach includes percutaneous endovascular therapy (PET) to restore blood flow, antiplatelet therapy, anticoagulation, or combination therapy, depending on the patient's status and available modalities. Warfarin is the standard anticoagulation therapy, although direct oral anticoagulation (DOAC) therapy is getting more popular. Here, we present a 60‐year‐old male patient with hyperthyroidism complicated by acute renal infarction, which was successfully treated with dabigatran, evident by non‐recurrence and restoration of blood flow in a follow‐up CT angiogram. This case report may open the door for the use of DOAC in acute renal infarction though more studies are needed to prove the efficacy.</p><h2>Other Information</h2><p dir="ltr">Published in: Clinical Case Reports<br>License: <a href="http://creativecommons.org/licenses/by/4.0/" target="_blank">http://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.1002/ccr3.6693" target="_blank">https://dx.doi.org/10.1002/ccr3.6693</a></p>2022-12-05T03:00:00ZTextJournal contributioninfo:eu-repo/semantics/publishedVersiontextcontribution to journal10.1002/ccr3.6693https://figshare.com/articles/journal_contribution/Renal_infarction_in_a_patient_with_thyrotoxicosis_induced_atrial_fibrillation_treated_successfully_with_dabigatran_a_case_report_and_literature_review/29413310CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/294133102022-12-05T03:00:00Z |
| spellingShingle | Renal infarction in a patient with thyrotoxicosis‐induced atrial fibrillation treated successfully with dabigatran, a case report and literature review Anas Al‐sadi (17746794) Biomedical and clinical sciences Cardiovascular medicine and haematology Clinical sciences Pharmacology and pharmaceutical sciences Renal infarction Acute kidney ischemia Atrial fibrillation Hyperthyroidism complications Anticoagulation therapy |
| status_str | publishedVersion |
| title | Renal infarction in a patient with thyrotoxicosis‐induced atrial fibrillation treated successfully with dabigatran, a case report and literature review |
| title_full | Renal infarction in a patient with thyrotoxicosis‐induced atrial fibrillation treated successfully with dabigatran, a case report and literature review |
| title_fullStr | Renal infarction in a patient with thyrotoxicosis‐induced atrial fibrillation treated successfully with dabigatran, a case report and literature review |
| title_full_unstemmed | Renal infarction in a patient with thyrotoxicosis‐induced atrial fibrillation treated successfully with dabigatran, a case report and literature review |
| title_short | Renal infarction in a patient with thyrotoxicosis‐induced atrial fibrillation treated successfully with dabigatran, a case report and literature review |
| title_sort | Renal infarction in a patient with thyrotoxicosis‐induced atrial fibrillation treated successfully with dabigatran, a case report and literature review |
| topic | Biomedical and clinical sciences Cardiovascular medicine and haematology Clinical sciences Pharmacology and pharmaceutical sciences Renal infarction Acute kidney ischemia Atrial fibrillation Hyperthyroidism complications Anticoagulation therapy |